Oncology News

This story has been amended from its original version. Dr. James Rooney is chief of hematology/oncology for Reliant Medical Group.

Once you're logged in, at the top of each article, video or slideshow you will see a list of your Facebook friends who recently visited Choose to share stories you'e read with your friends or turn sharing OFF to keep your reading experience anonymous .

Doctor was convicted in 2009 for taking patient data from Queen Elizabeth Hospital before he left to set up private practice in 2007 The Medical Council said there was no doubt Chan had taken the data in order to advertise his private practice.

The animal and their owner below know about the value of integrative and holistic veterinary care.

A new, state-of-the-art cancer center is coming to Clifton Park. New York Oncology Hematology, which bills itself as the region's largest cancer care provider, is planning construction of a 28,000 square foot Cancer Center, at the corner of Crossing Boulevard and Sitterly Road.

Tennessee Oncology, a physician-owned practice, has announced its adoption of the Breast Cancer Index, from bioTheranostics, Inc. This new cancer fighting tool addresses an unmet need no other commercially available test offers.

A new report for the first time suggests that being overweight increases a woman's risk of ovarian cancer, one of a growing list of cancers now linked to obesity or excess body fat.

Because of results seen in flat lab dishes, biologists have believed that cancers cells move through the body in a slow, aimless fashion, resembling an intoxicated person who cannot walk three steps in a straight line.

People fighting cancer might have to wait longer to see a cancer specialist in the coming decades, as demand for treatment outpaces the number of oncologists entering the workforce, a new report released Tuesday... People fighting cancer might have to wait longer to see a cancer specialist in the coming decades, as demand for treatment outpaces the ... (more)

Selvita , the largest independent drug discovery company in Central and Eastern Europe, will present new data at poster sessions at AACR Annual Meeting 2014, which will take place on April 5 - 9, 2014 at San Diego Convention Center, San Diego, California, USA.

WHEN faced with a devastating diagnosis and your whole world is crumbling around you, he has the calming voice and listening ear that gets you through.

The National Cancer Institute has progressed from a rate of nine months of survival to 30 with personalized treatments for patients diagnosed with lung cancer in metastatic stage, i.e., when the disease has spread to different parts of the body.

When Dr. Jeffery Ward joined a community oncology practice in Seattle, it had three doctors.

Fifteen years ago, a handful of poorly constructed, clearly biased studies purported to show that prayer was a legitimate medical tool.

CANCER patients paying more than $1000 a week for drugs needed to help keep them alive are demanding the Abbott Government act Severely ill Melbourne patients, leading oncologists and businessman Ron Walker want a cancer drug fund to save the lives of those unable to afford drugs, some costing more than $100,000 a year.

The annual meeting of the American Association for Cancer Research, which convenes in San Diego on April 5, is viewed by most drug-industry watchers as a second-tier medical conference.

Cancer patients from as far as Horsham have been receiving treatment in the new oncology unit at Stawell Hospital's state-of-the-art Community Rehabilitation Centre.

St. Luke's University Health Network is one of three sites nationwide chosen to enroll patients in a new study using the therapeutic agent PV-10 for late-stage liver cancer.

Champions Oncology , a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced it will report its financial and operational results for the third quarter ended January 31, 2014 on Thursday, March 13, 2014, after market close.

Journal of the National Cancer Institute , Vol. 103, No. 1. , pp. 16-20, doi:10.1093/jnci/djq463 The approval of a new drug for cancer treatment by the regulatory authorities, such as the United States Food and Drug Administration or European Medicines Agency, is usually based on the positive results of one or more randomized phase III clinical ... (more)